Christopher Sinz

Christopher Sinz is an accomplished professional in the field of drug discovery and chemistry, currently serving as Senior Vice President at Rezo Therapeutics since December 2024. Prior to this role, Christopher held the position of Vice President of Chemistry at Octant from October 2023 to December 2024 and occupied several leadership roles at Maze Therapeutics, including Vice President, Head of Molecular Sciences and Vice President, Head of Chemistry, from March 2020 to October 2023. Past experience includes key positions at MRL South San Francisco and Merck, where Christopher advanced from Senior Research Chemist to Director in various capacities, including Lead Optimization Chemistry and Exploratory Chemistry. Educational credentials include a PhD in chemistry from UC Irvine, a BS in Chemistry from the University of California, Berkeley, and a postdoctoral degree from Caltech.